Prof. Dr. Faysal Dane

Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment

Clinical Neurology and Neurosurgery, 2020

DOI 10.1016/j.clineuro.2020.105976 PMID 32531614 6 atıf (OpenAlex) Kaynak: OpenAlex

Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study

Journal of Oncology Pharmacy Practice, 2020

DOI 10.1177/1078155220924075 PMID 32419618 12 atıf (OpenAlex) Kaynak: OpenAlex

Long-term neuromusculoskeletal side effects and quality of life in nasopharyngeal cancer patients receiving radiochemotherapy

European Archives of Oto-Rhino-Laryngology, 2020

DOI 10.1007/s00405-020-05932-w PMID 32236708 4 atıf (OpenAlex) Kaynak: OpenAlex

P-209 Multicenter real life experience of biological agents in patients with metastatic colorectal cancer

Annals of Oncology, 2020

DOI 10.1016/j.annonc.2020.04.291 Açık erişimli tam metinKaynak: OpenAlex

Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study

Oncology Research and Treatment, 2019

DOI 10.1159/000502120 PMID 31437835 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study.

PubMed, 2019

PMID 31424664 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019

DOI 10.1007/s12094-018-1949-6 PMID 30229391 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

Neoadjuvant treatment in patients with locally advanced gastric cancer.

Journal of Clinical Oncology, 2019

DOI 10.1200/jco.2019.37.4_suppl.127 3 atıf (OpenAlex) Kaynak: ORCID

Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib

Journal of Oncology Pharmacy Practice, 2019

DOI 10.1177/1078155219890032 PMID 31793376 12 atıf (OpenAlex) Kaynak: OpenAlex

A rare case of primary rectal choriocarcinoma and review of the literature

Journal of Oncology Pharmacy Practice, 2019

DOI 10.1177/1078155219875510 PMID 31547751 9 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature

Journal of Oncology Pharmacy Practice, 2019

DOI 10.1177/1078155219879757 PMID 31615346 20 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy.

PubMed, 2019

PMID 31646797 6 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Glioblastomda İlk Seri Sistemik Tedavi

Turkiye Klinikleri Medical Oncology - Special Topics, 2019

Kaynak: OpenAlex

Beyin Tümörlerinde Beslenme

Turkiye Klinikleri Medical Oncology - Special Topics, 2019

Kaynak: OpenAlex

Primer Santral Sinir Sistemi Lenfomalarında Tanı, Evreleme ve Sistemik Tedavi

Turkiye Klinikleri Medical Oncology - Special Topics, 2019

Kaynak: OpenAlex

End-of-Life Considerations in Patients with Breast Cancer

Springer eBooks, 2019

DOI 10.1007/978-3-030-16792-9_33 Kaynak: OpenAlex

Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)

Clinical and Applied Thrombosis/Hemostasis, 2018

DOI 10.1177/1076029617753538 PMID 29455568 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Prognostic factors in early stage lung cancer patients: Retrospective single center data.

Journal of Clinical Oncology, 2018

DOI 10.1200/jco.2018.36.15_suppl.e20500 Kaynak: OpenAlex

Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study

Asia-Pacific Journal of Clinical Oncology, 2018

DOI 10.1111/ajco.12685 PMID 28429422 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

OncoTargets and Therapy, 2018

DOI 10.2147/ott.s106342 PMID 29403286 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

COMBINATION OF OxALIPLATIN, CAPECITABINE,t r a s t u z u m a b a n d c h e m o r a d io t h e r a p y INPATIENTS WITH GASTRIC CANCER

AYBU AVESIS, 2018

Kaynak: OpenAlex

Chordoma: a case series and review of the literature

Journal of Medical Case Reports, 2018

DOI 10.1186/s13256-018-1784-y PMID 30145982 34 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients

Journal of Gastrointestinal Cancer, 2018

DOI 10.1007/s12029-017-0047-2 PMID 29302856 19 atıf (OpenAlex) Kaynak: OpenAlex

Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study

Surgical Oncology, 2018

DOI 10.1016/j.suronc.2018.05.032 PMID 30217306 8 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study

OncoTargets and Therapy, 2018

DOI 10.2147/ott.s148917 PMID 29551901 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.

Journal of Clinical Oncology, 2018

DOI 10.1200/jco.2018.36.4_suppl.346 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Analysis of feasibility of geriatric assessment tools in elderly cancer patients and effects on anti-cancer treatment planning.

Journal of Clinical Oncology, 2018

DOI 10.1200/jco.2018.36.15_suppl.e22028 2 atıf (OpenAlex) Kaynak: OpenAlex

Effectiveness and safety of LMWH treatment in patients with cancer diagnosed with nonhigh-risk venous thromboembolism (VTE): Results of the Turkish observational study (TREBECA).

Journal of Clinical Oncology, 2017

DOI 10.1200/jco.2017.35.15_suppl.e21656 Kaynak: OpenAlex

EFFECTIVENESS AND SAFETY OF LMWH TREATMENT IN CANCER PATIENTS DIAGNOSED WITH NON-HIGH RISK VENOUS THROMBOEMBOLISM (VTE) - RESULTS OF TURKISH OBSERVATIONAL STUDY (TREBECA)

Bursa Uludag University - AVESIS, 2017

Kaynak: OpenAlex

EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.

Journal of Clinical Oncology, 2017

DOI 10.1200/jco.2017.35.15_suppl.e15028 Açık erişimli tam metinKaynak: OpenAlex

P3.15-007 A Retrospective Review of Small Cell Lung Cancer (SCLC) Patients Treated at Marmara University Hospital

Journal of Thoracic Oncology, 2017

DOI 10.1016/j.jtho.2017.09.1797 Açık erişimli tam metinKaynak: OpenAlex

Modified Glasgow prognostic score, prognostic nutritional index and ECOG score could be new prognostic factors for survival in metastatic gastric cancer

Annals of Oncology, 2017

DOI 10.1093/annonc/mdx369.049 Açık erişimli tam metinKaynak: OpenAlex

Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer

Journal of B.U.ON., 2017

PMID 29135102 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

Analysis of survival and prognostic factors in metastatic colorectal cancer patients treated with first line bevacizumab.

Journal of Clinical Oncology, 2017

DOI 10.1200/jco.2017.35.15_suppl.e15009 1 atıf (OpenAlex) Kaynak: OpenAlex

P1.03-040 Smokers Having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment - Single Center Experience

Journal of Thoracic Oncology, 2017

DOI 10.1016/j.jtho.2017.09.844 Açık erişimli tam metinKaynak: OpenAlex

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

Journal of Clinical Oncology, 2017

DOI 10.1200/jco.2016.72.0946 PMID 28654365 150 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Systemic chemotherapy of advanced soft tissue sarcomas

Journal of Oncological Sciences, 2017

DOI 10.1016/j.jons.2017.05.001 7 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

P2.03-042 EGFR Mutation and Erlotinib Efficacy in Turkish Oncoregistry

Journal of Thoracic Oncology, 2017

DOI 10.1016/j.jtho.2017.09.1293 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer

Oncology Research and Treatment, 2016

DOI 10.1159/000444272 PMID 27030981 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less

Anti-Cancer Drugs, 2016

DOI 10.1097/cad.0000000000000445 PMID 27768606 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

A study of the combination of oxaliplatin, capecitabine, and herceptin (trastuzumab) and chemoradiotherapy in the adjuvant setting in operated patients with HER2+gastric or gastro-esophageal junction cancer (TOXAG study)

Journal of Clinical Oncology, 2016

DOI 10.1200/jco.2016.34.4_suppl.tps182 21 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology)

Breast Care, 2016

DOI 10.1159/000448186 PMID 27721711 15 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors.

Nuclear medicine communications, 2016

DOI 10.1097/mnm.0000000000000401 PMID 26440568 49 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Changes in 18F-FDG-PET/CT tumor metabolism and prediction of pathologic complete response rates after neoadjuvant chemotherapy in hormone-positive breast cancer.

Journal of Clinical Oncology, 2016

DOI 10.1200/jco.2016.34.15_suppl.e12088 Açık erişimli tam metinKaynak: OpenAlex

Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life

International Journal of Clinical Pharmacy, 2016

DOI 10.1007/s11096-016-0393-3 PMID 27796777 21 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Benefit of Bevacizumab-Based Frontline Therapy in Patients with Metastatic Colorectal Cancer (mCRC): a Turkish Oncology Group Study

Journal of Gastrointestinal Cancer, 2016

DOI 10.1007/s12029-016-9823-7 PMID 27126591 2 atıf (OpenAlex) Kaynak: OpenAlex

End-of-Life Considerations in Patients with Breast Cancer

Springer eBooks, 2016

DOI 10.1007/978-3-319-26012-9_34 Kaynak: OpenAlex

Oral Alım Sorunu Olan Kanser Hastalarında Beslenme

Turkiye Klinikleri Medical Oncology - Special Topics, 2016

Kaynak: OpenAlex

Burden of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Turkey

Value in Health, 2016

DOI 10.1016/j.jval.2016.09.2170 Açık erişimli tam metinKaynak: OpenAlex

PET ile Onkolojide Tedaviye Yanıtın Değerlendirilmesi: Medikal Onkolog Gözüyle

Turkiye Klinikleri Nuclear Medicine - Special Topics, 2016

Kaynak: OpenAlex